Sporadic Degenerative Ataxia With Adult Onset: Natural History Study
Key facts
- Who runs it
- Ataxia Study Group
- Where
- Naples and Rome, ItalySee the 2 sitesAlso in 4 other countries, 12 sites
- Trial code
- Status
- Recruiting
- People taking part
- 300 people, planned
- Started
- Apr 2010
- Expected to end
- Dec 2030
- Type of study
- Observational, 2 groups
- Record updated
- 29 June 2017
Who can take part
- Age
- 40 years and older
- Sex
- Women and men
- Healthy volunteers
- Can take part
The registry criteria, word for word
Show all 19 criteriaShow less
Who can take part
- Progressive ataxia
- Disease onset after the age of 40 years
- Informative and negative family history (no similar disorders in first- and second-degree relatives; parents older than 50 years, or, if not alive, age at death of more than 50 years, no consanguinity of parents)
Who cannot take part
- no chronic intake of anticonvulsant drugs
- No onset of ataxia in association with stroke, encephalitis, sepsis, hyperthermia or heat stroke
- no other toxic causes; no malignancies
- no insulin-dependent diabetes mellitus; Imaging exclusion criteria:
- No evidence of multiple sclerosis, ischemia, hemorrhage or tumor of the posterior fossa
- Negative molecular genetic testing for FRDA (only required if there is no cerebellar atrophy on MRI, SCA1, SCA2, SCA3, SCA6, FMR1 premutation (only required if prominent tremor, cognitive impairment and signal abnormality on T2/FLAIR images in the middle cerebellar peduncle)
- antineuronal antibodies negative (only required, if disease duration less than 3 years)
- absence of signal abnormalities on T2/FLAIR-images except abnormalities compatible with MSA; Laboratory exclusion criteria:
- No established acquired cause of ataxia; Clinical exclusion criteria:
- no chronic diarrhea
- no unexplained visual loss
- no alcohol abuse
- no rapid progression (development of severe ataxia in less than 12 weeks)
- normal levels of vitamin B12
- VDRL negative
- normal thyreoid function
Where in Italy
Also in 4 other countries, 12 sites
- Department of Neuroscience, Federico II University NaplesNaples, ItalyContact: Alessandro Filla, MDTaking people
- Università Cattolica del Sacro CuoreRome, ItalyContact: Ilaria Anna Giordano, MDNo longer taking part
About the trial
What the trial wants to find out
The key goals of SPORTAX-NHS is to compare the phenotype of multiple system atrophy of cerebellar type (MSA-C) and sporadic adult onset ataxia of unknown aetiology (SAOA) and to determine the rate of disease progression in both groups including determination of the factors that predict the development of MSA-C vs. SAOA, and at which time after onset of ataxia, a reliable distinction between both disorders is possible.
Read full original descriptionShow less
The planned study will also allow to collect blood samples and other biomaterials from patients with sporadic ataxia, which will be useful for future genetic and biomarker studies.
The 2 groups in the trial
- sporadic adult onset ataxia
SAOA denotes the non-hereditary degenerative adult-onset ataxia disorders that are distinct from multiple system atrophy (MSA). SAOA is a group of ataxia of unknown etiology characterized by a slowly progressive cerebellar syndrome starting around the age of 50 years. Possibly is accompanied by signs of mild autonomic dysfunction that do not meet the criteria of severe autonomic failure required for a diagnosis of MSA.
- cerebellar multiple system atrophy
Multiple system atrophy of cerebellar type is a cerebellar syndrome with sporadic onset developing in midlife, with autonomic features of otherwise unexplained bladder dysfunction with or without erectile dysfunction in males, orthostatic hypotension and atrophy of the cerebellum, brainstem, and middle cerebellar peduncles.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Sporadic Degenerative Ataxia With Adult Onset: Natural History Study (SPORTAX-NHS)
- Record updated
- 29 June 2017